ROKIT Healthcare Inc. (KOSDAQ:376900)

South Korea · Delayed Price · Currency is KRW

48,350

-4,850 (-9.12%)

At close: Jul 16, 2026

188.66% (1Y)

Market Cap	971.89B +276.4%
Revenue (ttm)	30.61B +126.5%
Net Income	-4.32B
EPS	-292.20
Shares Out	15.83M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	211,001
Open	52,200
Previous Close	53,200
Day's Range	47,900 - 53,500
52-Week Range	14,120 - 153,800
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 10, 2026

About ROKIT Healthcare

ROKIT Healthcare Inc., a biotechnology company, provides hyper-personalized organ regenerative healthcare solutions in South Korea. The company offers skin regeneration therapy for the treatment of diabetic foot ulcers; cartilage regeneration delivers hyper-personalized therapeutic solutions for osteoarthritis patients; and kidney regeneration, a hyper-personalized treatment for chronic kidney disease (CKD). It also provides bioprinters; bioinks; Huma Media, a human adult stem cell culture media; HumaTein, a human cell-derived whole extracellul... [Read more]

Industry Biological Products, Except Diagnostic Substances

Founded 2012

Country South Korea

Stock Exchange KOSDAQ

Ticker Symbol 376900

Full Company Profile

Financial Performance

In 2025, ROKIT Healthcare's revenue was 26.25 billion, an increase of 100.19% compared to the previous year's 13.11 billion. Losses were -2.85 billion, -62.79% less than in 2024.

Financial Statements